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Psychedelic forum member preferences for carer experience and
consumption behaviour: Can 'trip sitters' help inform psychedelic
harm reduction services?
Abstract
Background. There is limited research on the provision of harm reduction services to people
who use psychedelics. Little is known about provision of care to people consuming
psychedelics outside of clinical trials.
Methods. We investigated how people who used psychedelics discussed their preferences for
care (or ‘trip sitting’) on two online forums: The Shroomery and DMT Nexus. A thematic
analysis of the discussion was conducted to better understand consumer preferences for harm
reduction services and resources.
Results. We identified two key themes: experience and remote sitting. Forum participants
valued trip sitters who had experienced psychedelic and other non-ordinary states of
consciousness, who had knowledge of the health and medical industry, psychedelic literature
and/or had previously cared for other psychedelic consumers. Forum participants also
identified the value of consuming a psychedelic without somebody who was in their physical
proximity, through communicating their plans to a remote trip sitter. The use of online tools
was identified as a way to maximise the benefit of privacy whilst retaining carer benefits.
Conclusion. Demand for trip sitters with lived psychedelic experience is likely influenced by
stigma and empathy. Trip sitters who could relate to the effects of psychedelics assisted
consumers in avoiding stigma whilst vulnerable under the effects of psychedelics. As such,
psychedelic harm reduction services should be delivered by peers to ensure care maximises
the benefits of empathy. Psychedelic harm reduction services should consider how remote
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workers could be employed. There is a clear demand for remote psychedelic care services
and to our knowledge this has not yet been explored.
Keywords. Psychedelic, harm reduction, online forum, lived experience, abstinence.
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Psychedelic forum member preferences for carer experience and
consumption behaviour: Can 'trip sitters' help inform psychedelic
harm reduction services?
Introduction
Harm reduction involves the dissemination of resources and strategies with the intent to
mitigate drug-related harm, without necessarily requiring abstinence (Simon & Lenton,
1998). Harm reduction also encompasses activities that maximise drug benefits, although
these positive dimensions of drug use are harder to recognise and support due to stigma and
drug prohibition (Móró and Rácz, 2013). Because harm reduction has prioritised health issues
relating to injected drugs, such as reducing the incidence of blood-borne virus transmission,
psychedelic harm reduction has received comparatively little attention. Besides drug
checking (Carvalho et al. 2014), ‘chill spaces’ or ‘care spaces’ at music events and festivals
have been identified as a key psychedelic harm reduction strategy (Quaranta, et al. 2017).
Such services allow people who are having difficult psychedelic experiences to engage with a
trip sitter (a person who provides care for a psychedelic consumer during the consumer’s
psychedelic experience, without providing psychotherapy) in a safe space. These services are
important because other psychedelic harm reduction resources (outside of clinical studies) are
mostly limited to the provision of psychotherapy before and/or after a challenging
psychedelic experience (Pilecki, et al. 2021).
Challenging psychedelic experiences, colloquially termed ‘bad trips’, have been extensively
documented in online, anecdotal bioassay reports (e.g. Erowid.org, n. d.) and clinical
investigations of substance-assisted psychotherapy (Kaelen, et al. 2018; Barrett et al., 2016;
Carbonaro et al., 2016; Garcia-Romeu & Richards, 2018). The psychedelic effect of ego
dissolution has been identified as a unique factor in challenging psychedelic experiences. As
in non-psychedelic psychological crises, self-centric thinking may be used as a defence

3

mechanism that leads to rumination and negative affect (Twemlow & Bowen, 2012). In
clinical settings, it is hypothesised that the intensity, duration and quality of challenging
aspects of acute psychedelic experiences may mediate positive therapeutic outcomes
(Carbonaro et al., 2016; Roseman, Nutt, & Carhart-Harris, 2018). As such, psychedelic harm
reduction services are well placed to not only reduce drug-related harm, but also engage in
opportunities for benefit maximisation (Tupper, 2008).
Clinical researchers have struggled to accurately predict challenging experiences using
historical and clinical factors (Ungerleider, et al. 1968; Adjay, et al. 2021). Meanwhile,
challenging psychedelic experiences in non-clinical settings have been hypothesised to also
be influenced by stigma, prohibition and the social construction of psychedelics (Bunce,
1979). Neuroticism, inexperience, recreational settings and large, open, outdoor spaces have
been identified as variables commonly associated with challenging psychedelic experiences
(Barrett, Johnson & Griffiths, 2017; Ona, 2018). The latter two variables are more prevalent
in festival settings than clinical environments, implying that more strictly controlled clinical
contexts decrease challenging psychedelic experiences. Yet many people use psychedelics in
festival settings without reporting to health or emergency services. Strategies for reducing
harm and maximising the benefit of psychedelic use are likely employed by the psychedelic
community, but there has been a disconnect between psychedelic harm reduction practice and
the research literature.
Since the 1960s there have been numerous organisations providing psychedelic harm
reduction spaces. One of the earliest examples of such models of care is the White Birds, who
provided trip sitting services in car parks outside Grateful Dead concerts. Currently, there are
several providers of such services, such as the Zendo Project, the AIDS Network Kootenay
Outreach and Support Society (ANKORS) and DanceWize, though only ANKORS
(Michelow & Dowden, 2015) and KosmiCare (Carvalho, et al. 2010; Carvalho, et al. 2014)
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services appear to have published service data relevant to trip sitting services. While
evaluations have highlighted service efficacy and the prominence of psychedelic use among
people using the service, psychedelic research is yet to explore consumer approaches towards
harm reduction and benefit maximisation.
Some have suggested that personal experience with psychedelics can enhance outcomes for
both trip sitters (Thal, et al. 2022b; Quaranta, et al. 2017) and psychedelic-assisted
psychotherapists (Phelps, 2017). Past experience with psychedelics might help trip sitters and
psychotherapists understand the subjective effects of psychedelics and related psychological
states, which are often ineffable (Shah, 2019; Elsey, 2017), and may help build
intersubjectivity and rapport (Kettner, et al. 2021). The inclusion of people who use drugs in
the provision of harm reduction services is also a means of reducing stigma, empowering
service users and improving service utilisation (Engel, et al. 2020). However, psychedelic
consumers’ understandings of psychedelic harm reduction and benefit maximisation is
currently unexplored. It is unclear how the value of lived experience differs between
psychedelic and other harm reduction contexts. Consequently, our project sought to
investigate consumers’ views on psychedelic harm reduction. In doing so, we took advantage
of the accessibility of data contained on online discussion forums with the aim of generating
data that could influence the design and delivery of related services.

Methodology
This paper analysed data from a larger project investigating psychedelic care discussion
amongst participants of psychedelic forums (see Thal, et al. 2022a; Thal, et al. 2022b). Most
data regarding drug-related harms have been obtained from clients receiving treatment for
unwanted outcomes of their drug use (Miller and Sønderlund, 2010). People who reduce
drug-related harms are thus a hard to research population, with online drug forums offering a
platform to access this group. Within online drug forums, English speaking, caucasian, young
5

males who are employed or studying and consuming drugs recreationally are highly
represented (Baggott, Erowid, Erowid, Galloway, & Mendelson, 2010; Temple & Brown,
2011; Orsolini et al., 2015). A vast majority of these forum participants also appear to reside
in the United States of America, the United Kingdom, Australia and New Zealand (Orsolini
et al., 2015). The demographics of online drug forum participants share similarities with
many people who use psychedelics. Within both groups, young, employed caucasian males
are highly represented.
We identified popular psychedelic forums and developed a search string through discussion
between researchers drawing on their personal understandings of online and offline
psychedelic communities and related care practices. The following terms were included in the
string: “carer”; “guide”; “holding space”; “hold space”; “shaman”; “sitter” and; “trip sit”. We
chose to conduct the search in two popular forums focussing on psychedelics: The Shroomery
and The DMT Nexus.
In a second step, we used our search string and the Google search engine with the
“site:website.com ‘search term’” function to identify relevant content. With the largest search
returning just under 50,000 results, we ceased reviewing results for each search term once we
received the message “In order to show you the most relevant results, we have omitted some
entries very similar to the X already displayed”. We then reviewed the title and abstract of
every search result. If the results were relevant to our research question, we followed the link
to the original forum thread and located the search term using the ctrl+f function. The entire
post was copied into a Microsoft Excel document page labelled with that search term.
LE and ST independently reviewed every forum post in the data set and attributed respective
preliminary codes in separate columns. All authors then discussed the preliminary codes and
subcodes and together developed them into final themes and subthemes. The themes
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discussed in this paper were selected due to their increased relevance to psychedelic care
outside of therapeutic settings, that is, in settings concerning psychedelic harm reduction.

Ethical considerations
When it is unfeasible to contact all online forum participants individually, Barratt and Lenton
(2010) suggest engaging forum participants as an ethical approach to researching forum
participants. As such, we gained consent for the project from the administrators of both
platforms, and we created respective threads on each forum that described our research and
provided participants an opportunity to opt out. Given the potential for participant discussion
of potential criminal or private activities to result in the incrimination or stigmatisation of
participants, we removed identifiable content that could be used for locating a participant’s
post or profile. We further ensured that quotations would not return related content in forum
or Google search engines (Enghoff and Aldridge 2019). In doing so, we aimed to enhance
transferability, credibility and participant representation by including as much unaltered
content as possible (Charmaz, 2004). We received ethics approval for this project from Edith
Cowan University (2020-01940-ENGEL).

Findings and Discussion
In this paper, we report on two themes appearing in an analysis of psychedelic care
discussion on online forums that we identified as relevant to psychedelic consumers’
perceptions of harm reduction services. These themes were labelled ‘experience’ and ‘remote
sitter’. There were a total of 244 posts in this subset of the data.
Experience
Discussions of work or life experience valued in psychedelic trip sitters were identified in
~80% of posts (n=195) in the subset of data used for this paper and labelled using the theme
‘experience’. ~26% (n=52) of these posts were from The DMT Nexus. Within this theme,
7

five sub-themes were identified and labelled ‘non-ordinary states’, ‘drug’, ‘health’,
‘information’, and ‘sitting experience’.
Forum participants remarked that trip sitters should have experience with ‘non-ordinary of
consciousness’ to empathically relate to the situation of a consumer and respond where
appropriate;
“Personally, I would prefer a sitter who has some experience with psychedelic drugs for a
breakthrough trip. Someone who knows what types of mindsets/feelings they can induce.”
“The sitter needs to have had the psychedelic experience on numerous occasions. This helps
the sitter understand and connect with what the consumer is going through.”
More specifically, forum participants consistently stated that they disliked trip sitters without
experience. They were concerned such trip sitters might engage in detrimental behaviours;
“An inexperienced person would be horrible. I've been there. I asked my friend to be my trip
sitter and she was so bad. She kept fucking with me and doing obnoxious things just for the
fact that I was tripping. At one point she had her hand around my neck. They think that since
you're tripping, it's okay to act weird and mess with you. A person with psychedelic
experience would know to let you vibe out and only react when the tripper is acting too
obscene.”
Participants suggested that confidence and experience with psychedelics might directly
translate to experience and skills as a trip sitter;
“If you wanted to be a carer, traditionally you had to get acquainted with the "terrain". If you
are confident and able to care for yourself then you should organically develop the necessary
skills.”
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“in a perfect world, the sitter should be very skilled and used to psychedelics, and someone
the tripper already knows and is close to. If someone is very experienced with these
substances it will often mean that they have the skills necessary to be a sitter.”
There has been a move away from top-down, institutionalised harm reduction, and towards
harm reduction that is peer generated and led (Bilgrei, 2017). Peers have been conceptualised
as intermediaries, bridging the relational gap between services and drug community
members. For example, peers have been found to be a uniquely useful vehicle for
disseminating injecting equipment (Lancaster, Seear & Treloar, 2015). Yet the value of peers
for harm reduction goes beyond community access – lived experience is key to combatting
the stigma responsible for a majority of harms associated with drugs (Engel, et al. 2020).
Both empathy for people who use drugs, and the resistance of stigma towards these
individuals, is likely encouraged by lived experience of drug use. Social stigma has been
implicated in deficits in empathy (Decety, Echols & Correll, 2010), while it has also been
suggested that psychedelic experience is linked to empathy increases (Blatchford, et al.
2020). Lived experience and empathy may improve the capacity of harm reduction workers
to relate to psychedelic consumers and avoid projection of stigma onto a person under the
influence of psychedelics. The impact of different types of lived drug experiences in general
and/or different psychedelic experiences on stigma and empathy, and the implications of
these experiences on capacities to provide psychedelic care deserves further exploration.
However, there are legal barriers to harm reduction workers gaining personal experience with
psychedelics (Barratt, et al. 2020). Within clinical trials of psychedelic-assisted psychotherapy, a
strategy for circumventing such obstacles among clinicians working with people in a psychedelic state
has been to provide clinicians with experiences of non-ordinary states of consciousness by means
other than illicit substances (Grof, 2014; Multidisciplinary Association for Psychedelic Studies,
2017). It is likely many trip sitters and medical practitioners without psychedelic experiences will be
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required to care for people under the influence of psychedelics, which if done poorly, may generate
challenging experiences (Quaranta, et al. 2017). Further research should address how to build trust
with people under the influence of psychedelics. Strategies for constructing drugs and drug experience
in positive ways is one potential approach (Engel, 2020; Engel, et al. 2020). Moreover, comparable

experiences of non-ordinary states of consciousness do not necessarily have to be induced by
psychoactive substances, but may also be facilitated by meditation, breathing, sensory
deprivation, and other methods (see Schmidt & Berkemeyer, 2018).
Not only did forum participants have a preference for trip sitters with psychedelic experience,
they also mentioned that experience with the specific psychedelic substance (or ‘drug’)
ingested by the consumer was an important quality of the trip sitter. This preference seemed
valued for similar reasons as experience with non-ordinary states of consciousness – it helped
the trip sitter understand the consumer’s experience;
“Someone who has tried LSD might not be a good choice for sitting a person who is going to
have psilocybin because they need to be familiar with the headspace of the drug the person is
using.”
“A trip sitter for 5-MeO-DMT should have a lot of familiarity with the substance. There are
possible intense body reactions 5-MeO-DMT can produce. I would worry lots of carers might
get scared and call emergency.”
Some forum participants’ desire for trip sitters who had drug-specific experience suggests
that in some cases, substitution of psychedelics for other strategies of consciousness
alteration may not be sufficient. The indescribable character of the psychedelic experience
(Shah, 2019; Elsey, 2017) may also undermine attempts to communicate the experiential
education provided by psychedelics. Furthermore, the importance of psychedelic experience
may extend beyond immediate effects of these substances, as the lived experience of people
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who use psychedelics encompasses specific experiences of stigma and community. These
non-immediate psychedelic experiences may be more relevant to the training of trip sitters
than for psychedelic-assisted psychotherapists; however, further delineation between these
and other psychedelic carer roles is required.
Some forum participants valued trip sitters with knowledge and experience in medicine. They
believed that these skills could assist the trip sitter’s capacity to distinguish between effects of
high doses of psychedelics and potentially problematic ‘health’ symptoms, which can be
complicated and highly dependent on the specific effects of different substances. For
example, unconsciousness following a high dose of vaporised DMT may not be a significant
concern, while unconsciousness following a low oral dose of MDMA may suggest health
complications.
Forum participants suggested that trip sitters should be informed about how to properly take
care of consumers during psychedelic experiences, and therefore suggested trip sitters be
familiar with certain literature, resources and ‘information’. Online resources commonly
referred to, besides The Shroomery and DMT Nexus forums, included Erowid.org, Bluelight
forums and YouTube videos of people consuming (primarily vaporised or smoked)
psychedelics. Popular texts included Shulgin and Shulgin’s PiHKAL (1991) and TiHKAL
(1997), the Multidisciplinary Association for Psychedelic Studies’ The Manual of
Psychedelic Support (2017), as well as a variety of works from Terrence McKenna and
Timothy Leary. While some educational resources discussed by forum participants are widely
acclaimed, particularly the resources produced by Shulgin and Shulgin (1991; 1997) and the
Multidisciplinary Association for Psychedelic Studies (2017), other material popular amongst
forum participants, such as the work of McKenna and Leary, have received extensive
criticism and might be seen to promote harmful or less socially cohesive psychedelic
consumption behaviours (Elcock, 2013).
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Many forum participants also discussed the educational value of videos showing people
consuming and under the influence of psychedelics. Most of these videos concerned smoked
or vaporised DMT, salvia or 5-MeO-DMT. Further, prominent video-distribution services
recently banned and demonetised content showing and promoting substance use, which has
reduced the accessibility of potentially harm reducing psychedelic videos (Google, n. d.).
Materials developed in collaboration between scholars and people who use drugs are a crucial
but largely absent psychedelic harm reduction resource.
Another important characteristic of trip sitters discussed by forum participants was that
ideally, they should be experienced in providing psychedelic care. Such ‘trip sitting
experience’ might allow trip sitters to act appropriately in various situations;
“You want someone fully trustworthy, experienced as a trip sitter if possible, and someone
who can remain calm him/herself, keep YOU calm if need be, and who won't abandon you or
panic and call the cops.”
“a sitter is only as good as what they know about their [sic] job as a sitter.”
Trip sitters with experience in trip sitting might even reduce anxiety in consumers;
“More importantly, having an experienced sitter may help with take-off anxiety.”
The wisdom and strategies of people with lived experiences have been valuable resources in
various mental health settings and might enhance trust in person-centred care (Davidson,
2016). Similarly, those with lived experience have their practice uniquely informed by their
experiences. These experiences might help foster constructive empathy with clients (Gilbert
and Stickley, 2012). Since there is no manualised and licensed approach for caring for people
who use psychedelics in recreational settings (as opposed to clinical studies), it is
comprehensible that lived experiences are accessible resources for the provision of
psychedelic care and that consumers feel less anxious around a carer who has had a similar
12

experience. However, experienced carers may project their expectations based on their past
experiences onto the person they are caring for. Since psychedelics may be linked to
increased suggestibility (Carhart-Harris et al., 2015) people who use psychedelics with an
experienced carer might readily adapt their perspectives and interpretations of the experience.

Remote sitter
Discussion of communicating plans to consume psychedelics to someone who would not be
in the physical presence of the consumer while they experienced psychedelic effects was
identified in ~21% of posts (n = 49) in the subset of data used for this paper and labelled
using the theme ‘remote sitter.’ ~71% of these posts (n = 35) were from The Shroomery.
While the remote sitter theme was not as prominent in the data as the experience theme, we
believed this theme is important to consider from the perspective of harm reduction service
delivery given the COVID-19 pandemic. There is a clear demand for a unique psychedelic
care service that provides opportunities for maximising the benefits of privacy and personal
space while reducing the harms of unmonitored psychedelic consumption. To our knowledge
such a service has not yet been discussed in the research literature. Within this theme, four
sub-themes were identified and labelled ‘inform’, ‘nearby’, ‘online’ and ‘phone’.
The subtheme ‘inform’ referred to discussion of telling friends “when and where” a forum
participant intended to consume psychedelics. One forum participant described this role as
being “available but not present”. Informing someone about intentions to consume
psychedelics and ensuring the remote sitter’s availability in case of physical or psychological
emergencies seemed to increase forum participants’ perception of security when consuming
psychedelics. Remote sitter posts categorised using the subtheme ‘nearby’ were seen to be
linked to this concept of availability. A geographically close but physically absent remote
sitter was able to avoid direct engagement with the psychedelic consumer, whilst being
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available to intervene should it become required. A total of 30 posts were labelled using this
subtheme ‘nearby’, which was the most common subtheme in the ‘remote sitter’ theme.
Most posts labelled with the ‘nearby’ subtheme expressed forum participants’ desires to be in
the same house as their remote sitter, but in different rooms. Such desires were often tied to
concerns that engaging with a person may have an unwanted influence on psychedelic
effects. Meanwhile, forum participants expressed a concurrent understanding that engaging
with a person could also be an important harm reduction measure.
“I really value the occasional trip alone with myself. What I have found to be a good
compromise is to have a sitter present in another room. It is very reassuring when going for a
breakthrough, for two good reasons. 1, if something were to happen to you during the trip
(stumbling out the room, vomiting...), the sitter would be there to help. 2, if you happened to
have a bad experience, you could integrate it by talking it out.”
Posts often suggested having carers within earshot, who would engage with the consumer at
the consumer’s spoken request.
“have someone in another room/close by that you can call out for if you need help.”
A smaller number of posts advocated for unobtrusive monitoring of consumers.
“it's always better to have a clear headed individual monitoring the situation.”
“I stayed in another room and only popped in a few times to make sure things were going
well.”
Posts conflicted in the extent of the monitoring they advocated for, and participants held
different opinions in the debate of what was earlier described as a “compromise.” The
following participant portrays such a compromise as a balance between idealism and safety.
14

“NOT having a sitter is ideal. BUT, note that it is always safer to have a sitter around.”
It becomes apparent that preferences for the physical proximity of carers and the degree of
interaction between carers and consumers varied among forum participants’. As described in
a previous publication (Thal, et al. 2022b), forum participants’ preferences for interaction and
availability was quite variable. It was indicated that carers might be helpful to prevent or
control undesirable situations and controlling hazards. Compared to participants in clinical
studies with psychedelics which exhibit a high degree of safety, control and supervision
(Johnson et al. 2008), our study seems to evidence preferences for optional, flexible and
diverse harm reduction measures, with these care preferences varying between consumers. .
Participants recommended a number of ‘online’ platforms for utilising a remote sitter,
including The DMT Nexus and Shroomery forums, tripsit.me chat rooms and generic social
media applications. The number of people in these spaces was seen as an advantage by some
forum participants.
“many heads are better than one.”
Of course, preference for online remote sitters depended on personal comfortability with
digital spaces.
“Nothing wrong with an online trip sitter if you dont mind being online.”
Multiple participants were vocal in their criticism of remote sitters, suggesting remote sitters
were not a useful safety mechanism in emergencies.
“Still, there are plenty of cases (I witnessed a few myself) when things went remarkably
wrong. In most of such situations the idea of speed-dialing someone or chatting over net or
anything alike is just a joke.”
15

Other participants implied remote-sitters may be more useful for integration than for the
provision of support to people currently under the influence of psychedelics.
“Online, through skype or something would be cool for afterwards... possibly next day even
depending on how intense the experience is.”
Besides some limited analysis of online forums (Thal, et al. 2022a; Thal, et al. 2022b) and a
unique study of online ayahuasca ceremonies undertaken by followers of the Santo Daime
religion following COVID-19 restrictions (Hartogsohn, 2022), online psychedelic care
services are largely unexplored. The provision of social support through online peer
counselling is being explored (Fukkink, 2011) and online therapeutic interventions have
evidenced decreases in anxiety and depression (e.g., Cohen & Kerr, 1999; Kessler et al.,
2009). Likewise, chat services for acute crises have been shown to reduce harms (Gould et
al., 2021). The necessity of these services has increased dramatically during the COVID-19
pandemic. However, clients may show less engagement and openness in online settings
(Barker & Barker, 2022). Integrated digital technologies have been accused of providing an
‘impoverished’ psychedelic experience, although this is likely linked to deficits in IT literacy
and the digital divide (Hartogsohn, 2022). Regardless, even online interpersonal exchange are
likely to offer some relief to consumers in cases of mild psychological distress. As such,
harm reduction services should explore ways to leverage online platforms to minimise
potential harms and maximise the benefits that were described by our participants.
Psychedelic-assisted psychotherapy guidelines suggest that therapists remind distressed
participants that their current state of mind is the consequence of their consumption of
psychoactive substances and that this state will subside (Phelps, 2017). This is something
remote-sitters can also do to support consumers. Likewise, having someone to talk about the
experience and assist with integration could be helpful. Nevertheless, complex psychological
16

or even minor physiological issues cannot receive adequate attention from someone who is
not physically present with the consumer. Future research should investigate how best to
utilise online support to care for people who use psychedelics. It is also worth considering
whether online debriefing or “integration” services are perceived as valuable by people who
use psychedelics, and how they value these services differently to other forms of psychedelic
care.
Another ‘remote sitter’ subtheme categorised posts that discussed having people to contact
via ‘phone’ during a psychedelic experience. Such a strategy was portrayed as more
important for mental, rather than physical crises.
“Someone you trust, who knows what you're doing, and is available by pre-programmed
phone number. Just a soothing voice if necessary.”
A number of other participants also discussed the use of such “pre-programming” or “speed
dial” as well alerting the remote sitter of the intended psychedelic consumption and
possibility of their phone call.
“Make them promise to pick up the phone if you call.”
Several forum participants indicated that having a trusted person readily available via
telephone in case of distress and/or emergency may offer some sense of safety and peace of
mind when using psychedelics. Emergency hotlines (e.g., police and ambulance) and
telephone services available for acute psychological distress (e.g., crisis line services) are
already used on a global scale, although their utility can be critiqued (Hoffberg et al., 2020).
As evidenced by previous investigations regarding consumer preferences (Thal, et al. 2022a),
having someone to reach out to in case of an emergency with whom a preexisting relationship
has been established may allow for a reduction in anxiety. A pre-selected sober person who
17

knows the consumer well might be best placed to assess the situation, provide direct supports
and call for professional help if needed.

Limitations
While there are many online forums concerning psychoactive substances, the current study
only focused on two forums: The Shroomery and DMT Nexus. Alternative drug information
sources or social media platforms that do not focus exclusively psychedelics, like Erowid.org,
Psychonautwiki.org, Facebook or Twitter were not considered in this review. Forums may
not accurately represent people who use psychedelics more frequently, particularly people
that are less educated, less healthy or of other racial and ethnic backgrounds (Lyke & Kuti,
2019). The review was further limited by the predetermined search terms and the immense
number of search results. Future investigations should extend beyond the scope of these two
platforms and could also include self-report questionnaires and semi-structured interviews
with community members and stakeholders.

Presuming participants are predominantly caucasian, western males (Baggott, Erowid,
Erowid, Galloway, & Mendelson, 2010; Temple & Brown, 2011; Orsolini et al., 2015), the
demographics of drug forum participants might generally be considered a more
privileged/less stigmatised group. This provokes consideration of whether difficult
psychedelic experiences, while regularly discussed, were less common for these participants
than they may be for consumers in other contexts. It is possible that forum participants had an
enhanced capacity to frame themselves and their challenging psychedelic experiences in
positive ways and to perceive positive outcomes as a result. Whether it be due to inaccessible
positive discourse (Engel, et al. 2020) and/or diverse people being more likely to encounter
challenging psychedelic experiences, accessing diverse trip sitters capable of positive
psychedelic representations could be a significant challenge for psychedelic harm reduction.
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Conclusions
There is a lack of research literature concerning psychedelic care spaces, despite clear
demand for such spaces at public events (Carvalho, et al. 2010; Carvalho, et al. 2014;
Multidisciplinary Association for Psychedelic Studies, 2017). Our study suggests the demand
for such care spaces extends to everyday, non-event contexts. Forum participants recognised
divergent needs of people consuming different types of psychedelics, particularly iboga,
salvia and 5-MeO-DMT, suggesting the concept of substance specific care spaces should also
be addressed. Substance specific care spaces may be less important for public events,
considering participant discussion of their avoidance of more physically debilitating
substances such as iboga, salvia and 5-MeO-DMT in social contexts. It should also be
recognised that substance specific spaces pose an additional risk of exclusion and stigma
(Engel, 2020).
While many participants in our study emphasised the utility of remote sitters, this concept has
not shown positive results in clinical studies. In the early stages of the first wave of
psychedelic research, clients, on occasions, were free to take substances to their homes for
self-administration, or were left alone with untrained, sometimes disinterested observers and
a recording device. This resulted in traumatic and detrimental effects in a number of cases
(Cutner, 1959; Hausner & Dolezal, 1963). It must be stressed, however, that clients in a
clinical trial are also a unique cohort, who will typically have had to meet various eligibility
criteria to be eligible for inclusion in the study (including, at present, criteria related to mental
health such as a clinical diagnosis with anxiety or post-traumatic distress disorder). We must
take care, therefore, in drawing lessons from the experiences of those involved in clinical
trials since their experiences, motivations, needs and practices might differ from those of
other populations.
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